HighTower Advisors’s Healthcare Services Acquisition Corporation Class A Common Stock HCAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-187,478
Closed -$1.84M 3492
2022
Q2
$1.84M Sell
187,478
-5,200
-3% -$51.1K ﹤0.01% 1310
2022
Q1
$1.89M Sell
192,678
-30,000
-13% -$293K ﹤0.01% 1408
2021
Q4
$2.18M Sell
222,678
-1,645
-0.7% -$16.1K ﹤0.01% 1320
2021
Q3
$2.19M Sell
224,323
-17,700
-7% -$171K 0.01% 1203
2021
Q2
$2.34M Sell
242,023
-48,777
-17% -$474K 0.01% 1144
2021
Q1
$2.82M Buy
+290,800
New +$2.91M 0.01% 962

Other funds holding HCAR

HighTower Advisors's HCAR Position: Q3 2022 in Review

HighTower Advisors sold out of Healthcare Services Acquisition Corporation Class A Common Stock (HCAR) in Q3 2022, closing a stake of 187,478 shares — an estimated $1.84M sold.

HighTower Advisors first reported a position in HCAR in Q1 2021 and held it in 6 quarters. The position peaked at $2.82M in Q1 2021. 78 funds tracked by Wall St. Rank hold HCAR as of Q3 2022.

  • HighTower Advisors reported no remaining Healthcare Services Acquisition Corporation Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • HighTower Advisors sold 187,478 Healthcare Services Acquisition Corporation Class A Common Stock shares in Q3 2022, an estimated $1.84M.
  • HighTower Advisors first reported a position in Healthcare Services Acquisition Corporation Class A Common Stock in Q1 2021 and held it in 6 quarters.
  • HighTower Advisors's Healthcare Services Acquisition Corporation Class A Common Stock position peaked at $2.82M in Q1 2021.
  • 78 funds tracked by Wall St. Rank held Healthcare Services Acquisition Corporation Class A Common Stock as of Q3 2022.

Based on HighTower Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.